Picture of Kdventures AB logo

KDV B — Kdventures AB News Story

0.000.00%
se flag iconLast trade - 00:00
FinancialsSpeculativeMicro CapSucker Stock

Brief: Karolinska Development Says Modus Therapeutics Raises SEK 28.3 Mln

Aug 28 (Reuters) - Karolinska Development AB KDEV.ST:

MODUS THERAPEUTICS RAISES SEK 28.3 MILLION WITH 189% SUBSCRIPTION RATE

PROCEEDS FROM RIGHTS ISSUE ARE INTENDED TO FINANCE CONTINUED DEVELOPMENT OF DRUG CANDIDATE, SEVUPARIN, FOR TREATMENT OF CHRONIC KIDNEY DISEASE

Source text: ID:nGNE1v1kyJ

Further company coverage: KDEV.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Kdventures AB

See all news